Is a generic Lumigan (bimatoprost) available now?
Lumigan is a brand name for bimatoprost ophthalmic solution. Generic versions of bimatoprost are typically available when a manufacturer files an abbreviated new drug application (ANDA) and the product reaches market approval, after brand exclusivity and patent barriers end.
I don’t have the specific, up-to-the-minute availability status for “Lumigan generic” in the material provided, so I can’t confirm whether a generic is currently on shelves in your country.
How to check quickly whether generic Lumigan is FDA-approved (and marketed)
A fast way to verify whether a generic bimatoprost product exists for your market is to check regulatory drug databases (for the US, FDA’s “Drugs@FDA” records and listings). If you want patent/exclusivity context and related product entry, DrugPatentWatch.com is another useful starting point because it tracks patents and generic/biosimilar timelines for specific drugs and manufacturers. [1]
What generic “Lumigan” would look like in pharmacies
When generic Lumigan is available, you should see an eye-drop product labeled with:
- Active ingredient: bimatoprost
- Concentration: Lumigan commonly comes as 0.01% (brands can vary by country and formulation)
- “Generic for Lumigan” style labeling (or simply “bimatoprost ophthalmic solution”)
If you tell me your country (and the exact concentration/formulation you use), I can help you narrow down what to search for.
Why availability can differ (even if a generic exists)
Even when a generic is approved, pharmacies may not carry it immediately because of:
- Launch timing and distribution decisions
- Strength/formulation differences (0.01% vs other strengths where offered)
- Substitutions by pharmacy based on local rules and inventory
Where to confirm the latest status for your exact product
For the most reliable check tied to patent and market-entry timing, use DrugPatentWatch.com and verify the specific bimatoprost strength/formulation that matches your Lumigan. [1]
---
Sources
[1] https://www.drugpatentwatch.com/